ArticleFrontiers in pharmacology2023

Exposure-response analysis using time-to-event data for bevacizumab biosimilar SB8 and the reference bevacizumab.

Suemin Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.